Taurine
In clinical developmentAlso known as Aminoethylsulfonic acid, Aminosyn-PF 10 %, Sulfite-Free, Aminosyn-PF 7%, PremaSol+5 more
Aminoethylsulfonic acid, Aminosyn-PF 10 %, Sulfite-Free, Aminosyn-PF 7%, PremaSol, Taurine-Vitamin B6, Taurineold, Trophamine, Trophamine 10 %, Trophamine 6 %.
Recent clinical, regulatory, research and industry developments relating to this drug.
Taurine Supplementation as a Novel Therapeutic Approach for Neurocognitive Symptoms in Long COVID
Taurine Affects the Progression of Senile Cataract: a Single-arm Pre-post Intervention Study
Taurine deficiency as a driver of aging.
Taurine for Early Left Ventricular Recovery in Peripartum Cardiomyopathy
Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Taurine for Early Left Ventricular Recovery in Peripartum Cardiomyopathy
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes4
Journals, researchers & institutions
- Amino acids1
- Science (New York, N.Y.)1
- Scientific reports1
- Ali AM1
- Andersen JK1
- Baumert P1
- Biswal BK1
- Chamoli M1
- Charzynska A1
- Chattopadhyay N1
- Chawla AS1
- Broad Institute of Harvard and MIT1
- Buck Institute for Research on Aging1
- Centre for Healthy Longevity1
- Columbia University1
- Columbia University Irving Medical Center1
- CSIR-Central Drug Research Institute1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across the same disease area as Taurine in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials